The specialists in the Center for Gastrointestinal Oncology are experienced in all types of gastrointestinal cancer, including colon, pancreatic, stomach, and liver cancer. We offer the latest in clinical care and a wide range of resources — from nutritional advice to integrative therapies — to support you throughout treatment.
At the Center for Gastrointestinal Oncology, we understand that every patient is unique. We work closely with you to offer a tailored, personalized therapy plan that takes your individual needs into account.
Our team of specialists includes medical oncologists, surgeons, and radiation oncologists who focus exclusively on gastrointestinal cancers, including colon cancer, pancreatic cancer, stomach cancer, liver cancer, neuroendocrine cancer, and esophageal cancer.
We offer the most advanced treatments for gastrointestinal cancers, including access to clinical trials.
We understand that cancer treatment can be challenging both physically and emotionally. Our patients, and their families, have access to a range of support services, including nutrition counseling, support groups, and integrative (or complementary) therapies such as acupuncture and Reiki.
If you have a family history of gastrointestinal cancer, such as colon, stomach, pancreatic or esophageal cancer, you can meet with our genetic counselors for an in-depth risk assessment, including a detailed family lineage analysis, genetic evaluation using state-of-the-art molecular tests, and tailored cancer screening and prevention recommendations.
The gastrointestinal cancers we treat include:
We view every patient as an individual, with unique needs and expectations. This understanding guides us in creating a treatment plan that takes your lifestyle and goals into account.
As a new patient, you'll have your tumors tested for molecular alterations, the results of which will help form the basis of your therapy.
Our scientists head a variety of local and international research studies investigating the molecular makeup of colorectal, esophageal, stomach, neuroendocrine, and other gastrointestinal cancers. This allows us to offer a range of innovative clinical trials that may benefit patients today and in the future.
In addition to offering the latest in clinical care, we provide a wide range of resources — from support groups to nutritional advice to integrative therapies — to support you physically and emotionally throughout your treatment.
We believe that there is more to caring for you than just treating your diagnosis. With that in mind, we offer a comprehensive range of services. These include:
Given the individual approach necessary to treating your gastrointestinal cancer, your treatment team may include a variety of specialists who can address your specific needs.
Charles Fuchs, MD, MPH
Shilpa Grover, MD, MPHSapna Syngal, MD, MPH
Thomas Abrams, MDAdam Bass, MDPankaj Bhargava, MD, MBBSGabriel A. Brooks, MDJennifer Ang Chan, MD, MPHJames Cleary, MD, PhDPeter Enzinger, MDWendy Garrett, MD, PhDWolfram Goessling, MD, PhDNadine J. McCleary, MD, MPHMatthew Kulke, MDRobert Mayer, MDJeffrey Meyerhardt, MD, MPHKimmie Ng, MD, MPHDeborah Schrag, MD, MPHRamesh Shivdasani, MD, PhDBrian Wolpin, MD Matthew Yurgelun, MD
Alec Kimmelman, MD, PhDJason Lee, MDHarvey Mamon, MD, PhD
Stanley Ashley, MDMonica Bertagnolli, MDRonald Bleday, MDElizabeth Breen, MDThomas Clancy, MDJoel Goldberg, MDJennifer Irani, MDSara Russell, MDRichard Swanson, MDJiping Wang, MD, PhDMichael Zinner, MD
Nina Grenon, RN, APRN, BCMary Rapp, RN, MSN, NPRobin Sommers, DNP, ANP-BC, AOCNP
Eileen Regan, RN, BCN, ONCMaria Shellock, RN
Chistine Lilienfeld, RN, BSN, ONCPatricia Rizzo, RN, BSNLeslie Yiankos, RN, BSN
Rachel Allende, LICSW (for Spanish- and Portuguese-speaking patients)Jane Bausch, LICSWSusan Englander, MSW, LICSWBruce MacDonald, MSW, LICSWSara Nemitz, MSW, LICSW (for inpatients staying at Brigham and Women's Hospital)
We believe an active clinical research program is vital for providing outstanding care. Our physician-scientists conduct clinical trials to build a precise understanding of how cancer develops and how it can be treated. That research, in turn, informs our approach to your individual treatment needs.
Among other research initiatives, we are studying risk factors for diseases such as colon cancer, stomach cancer, and pancreatic cancer, using information on the diet, lifestyles, and medical histories of more than 170,000 men and women.
We are also collecting blood samples and tumor specimens, which allows us to look at molecular and genetic alterations that may signal a risk factor for particular cancers.
Studying the tumors will help us better understand how normal cells become cancer cells and how we can create better drugs to delay or prevent these changes.
We are also constantly conducting clinical trials to develop new treatments for patients with gastrointestinal cancers. These trials will help us define more effective therapies for patients now and in the future.
Our recent breakthroughs in gastrointestinal cancer research include these discoveries:
If you have never been seen before at Dana-Farber/Brigham and Women's Cancer Center, please call 877-442-3324 or use this online form to make an appointment.
If you are a current patient, please call the center's main number at 617-632-4500.
If you believe you are at risk for a gastrointestinal cancer, and wish to schedule an appointment in the Risk and Prevention Clinic, call 617-632-2178.
Center for Gastrointestinal OncologyDana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: